C07D 241/20
Nitrogen atoms
Official title: Nitrogen atoms (nitro radicals C07D241/16)
C07D241/20 (Nitrogen atoms) appears on 670 US grants and 775 published applications in this corpus.
Search patents in C07D- Granted patents
- 670
- Published applications
- 775
- Assignees
- 367
- Inventors
- 2,561
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 1 | 0 |
| 1978 | 6 | 0 |
| 1979 | 8 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 2 | 0 |
| 1983 | 4 | 0 |
| 1984 | 10 | 0 |
| 1985 | 7 | 0 |
| 1986 | 4 | 0 |
| 1987 | 7 | 0 |
| 1988 | 6 | 0 |
| 1989 | 10 | 0 |
| 1990 | 6 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 6 | 0 |
| 1998 | 2 | 0 |
| 1999 | 9 | 0 |
| 2000 | 7 | 0 |
| 2001 | 9 | 3 |
| 2002 | 8 | 8 |
| 2003 | 11 | 26 |
| 2004 | 12 | 38 |
| 2005 | 12 | 30 |
| 2006 | 19 | 24 |
| 2007 | 21 | 32 |
| 2008 | 13 | 29 |
| 2009 | 15 | 34 |
| 2010 | 23 | 45 |
| 2011 | 22 | 37 |
| 2012 | 29 | 27 |
| 2013 | 24 | 32 |
| 2014 | 33 | 40 |
| 2015 | 48 | 55 |
| 2016 | 26 | 28 |
| 2017 | 36 | 37 |
| 2018 | 27 | 32 |
| 2019 | 31 | 32 |
| 2020 | 32 | 39 |
| 2021 | 16 | 28 |
| 2022 | 12 | 24 |
| 2023 | 16 | 29 |
| 2024 | 19 | 35 |
| 2025 | 20 | 21 |
| 2026 | 17 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Aptamer nucleic acid molecule, and complex and application thereof23 Jun 2026US 12,662,676 B2East China University of Science and Technology
- Oxadiazolopyrazines and oxadiazolopyridines useful as mitochondrial uncouplers16 Jun 2026US 12,655,156 B2Virginia Tech Intellectual Properties, Inc.
- Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors26 May 2026US 12,637,413 B2Autobahn Therapeutics, Inc.
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Compound serving as ddr1 kinase inhibitor, and medicine20 Aug 2026US 2026/0242343 A1Nippon Shinyaku Co., Ltd.
- At2 antagonists for non-addictive pain relief20 Aug 2026US 2026/0242357 A1Board of Regents, The University of Texas System
- Therapeutic compounds and compositions13 Aug 2026US 2026/0234110 A1Agios Pharmaceuticals, Inc.
- Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins6 Aug 2026US 2026/0224755 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Heteroaryl derivatives as CFTR modulators94US 8,299,099 B2Vertex Pharmaceuticals Incorporated · 2012
- Heteroaryl sulfonamides and CCR292US 7,622,583 B2ChemoCentryx, Inc. · 2009
- Antiatherosclerotic 1-piperazinecarbonyl compounds79US 4,439,606 AAmerican Cyanamid Company · 1984
- Inhibitors of p3875US 5,945,418 AVertex Pharmaceuticals Incorporated · 1999
- Capsaicin receptor ligands74US 6,723,730 B2Neurogen Corporation · 2004